Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Ivax to develop treatment for cystic fibrosis with CBR

June 7, 2000

Worldwide approval sought for novel allergy and asthma therapy Xolair

June 6, 2000

Aurora Biosciences to collaborate with Cystic Fibrosis Foundation

June 6, 2000

3M's QVAR asthma inhaler approved by Health Canada

June 5, 2000

Development progresses for Nuvance in the treatment of asthma

June 2, 2000

Bayer decides to discontinue development of Bay-44-3428 for asthma

June 2, 2000

TOBI trial in young CF patients with mild lung disease commences; European patent granted

June 2, 2000

Selective human NK3 receptor antagonists designed at Sanofi-Synthelabo

May 31, 2000

Potent histamine H3 receptor ligands developed by Schering-Plough

May 30, 2000

Pfizer's new adenosine A2A receptor agonists useful for respiratory and inflammatory diseases

May 29, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...